Background
CA 125 belongs to a family of hybridoma – defined tumour markers, it has a protein structure and possesses carbohydrate side chains. Its principle use is in monitoring the treatment of Ovarian Carcinoma.
Reference ranges
0 – 35 kU/L
Specimen requirements
Serum (10 ul) is the recommended sample type for this assay.
Turnaround time
24 hours